These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1773 related items for PubMed ID: 12670638

  • 21. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Milan DJ, Saul JP, Somberg JC, Molnar J.
    Cardiology; 2017; 136(1):52-60. PubMed ID: 27554842
    [Abstract] [Full Text] [Related]

  • 22. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K, Ahmad M, Carrington M, Ioannou A, Taylor J, Razvi Y, Papageorgiou N, Mead GE, Nevis IF, D'Ascenzo F, Wilton SB, Lambiase PD, Morillo CA, Kwong JS, Providencia R.
    Cochrane Database Syst Rev; 2024 Jun 03; 6(6):CD013255. PubMed ID: 38828867
    [Abstract] [Full Text] [Related]

  • 23. Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
    Mykytsey A, Bauman JL, Razminia M, Zheutlin T, Wang T, Saleem M, Leal S, Kehoe RF.
    J Cardiovasc Pharmacol Ther; 2007 Mar 03; 12(1):36-43. PubMed ID: 17495256
    [Abstract] [Full Text] [Related]

  • 24. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
    Am J Cardiol; 2001 Sep 15; 88(6):640-5. PubMed ID: 11564387
    [Abstract] [Full Text] [Related]

  • 25. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F, Candinas R, Frielingsdorf J.
    Herz; 1993 Feb 15; 18(1):20-6. PubMed ID: 8454249
    [Abstract] [Full Text] [Related]

  • 26. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS, Zehender M.
    Ther Umsch; 2000 May 15; 57(5):324-32. PubMed ID: 10859993
    [Abstract] [Full Text] [Related]

  • 27. The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF.
    Derakhchan K, Villemaire C, Talajic M, Nattel S.
    Cardiovasc Res; 2001 Apr 15; 50(1):75-84. PubMed ID: 11282080
    [Abstract] [Full Text] [Related]

  • 28. Atrial fibrillation: choosing an antiarrhythmic drug.
    Rudo T, Kowey P.
    Curr Cardiol Rep; 2006 Sep 15; 8(5):370-6. PubMed ID: 16956453
    [Abstract] [Full Text] [Related]

  • 29. Arrhythmias in the intensive care patient.
    Trappe HJ, Brandts B, Weismueller P.
    Curr Opin Crit Care; 2003 Oct 15; 9(5):345-55. PubMed ID: 14508146
    [Abstract] [Full Text] [Related]

  • 30. Drug choices in the treatment of atrial fibrillation.
    Reiffel JA.
    Am J Cardiol; 2000 May 25; 85(10A):12D-19D. PubMed ID: 10822036
    [Abstract] [Full Text] [Related]

  • 31. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN.
    J Cardiovasc Pharmacol Ther; 2010 Dec 25; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [Abstract] [Full Text] [Related]

  • 32. Antiarrhythmic drug therapy of atrial fibrillation.
    VerNooy RA, Mounsey JP.
    Cardiol Clin; 2004 Feb 25; 22(1):21-34. PubMed ID: 14994845
    [Abstract] [Full Text] [Related]

  • 33. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
    Singh BN.
    J Cardiovasc Electrophysiol; 1999 Feb 25; 10(2):283-301. PubMed ID: 10090235
    [Abstract] [Full Text] [Related]

  • 34. Sotalol: An important new antiarrhythmic.
    Anderson JL, Prystowsky EN.
    Am Heart J; 1999 Mar 25; 137(3):388-409. PubMed ID: 10047618
    [Abstract] [Full Text] [Related]

  • 35. Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
    Jung F, DiMarco JP.
    Cardiol Clin; 1996 Nov 25; 14(4):507-20. PubMed ID: 8950053
    [Abstract] [Full Text] [Related]

  • 36. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
    Pedersen OD, Brendorp B, Elming H, Pehrson S, Køber L, Torp-Pedersen C.
    Card Electrophysiol Rev; 2003 Sep 25; 7(3):220-4. PubMed ID: 14739717
    [Abstract] [Full Text] [Related]

  • 37. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
    Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M.
    Europace; 2011 Mar 25; 13(3):329-45. PubMed ID: 21227948
    [Abstract] [Full Text] [Related]

  • 38. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S.
    Am Heart J; 2001 Feb 25; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [Abstract] [Full Text] [Related]

  • 39. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
    N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
    Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp-Pedersen C.
    Circulation; 2001 Jul 17; 104(3):292-6. PubMed ID: 11457747
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 89.